Claire McCaskill actually said...

"I think it is misleading to act as if this is a problem with four drugs. This is the business model."

"I think, Mr. Pearson, honestly, to give the impression that these were isolated incredibly large price increases is just misleading."

"Valeant has said that they have turned over a new leaf, that they have had a conversion on the road to Damascus."

"Well, we are in trouble if you are---over the last year, with everything that has gone on in the company, if you are 78 percent over last year in the top 30 selling drugs, if you are an industry leade..."